Herbetom Controle urique rein detox
Food supplement declared in France, decision dated 1 April 2025
Herbetom Controle urique rein detox (Bioerum) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Terminalia bellerica 1,000 µg per day, Tilia platyphyllos 75 µg per day, Erica cinerea 75 µg per day, Betula pendula 75 mg per day, Smilax aspera 75 µg per day. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- Bioerum
- Food business operator placing the product on the market
- Bioserum Laboratorios SL
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Tablet
- Daily dose
- 2 par jour
- Intended populations
- Men
- Objectives stated by the manufacturer (these are not authorised claims)
- Autre : acide urique
Declaration 146021, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Terminalia bellerica (Gaertn.) Roxb. | Fruit | Extrait sec hydroalcoolique | 1,000 µg |
| Tilia platyphyllos Scop. | Feuille | Extrait sec hydroalcoolique | 75 µg |
| Erica cinerea L. | Fleur | Extrait sec hydroalcoolique | 75 µg |
| Betula pendula Roth | Feuille | Extrait sec hydroalcoolique | 75 mg |
| Smilax aspera L. | Jeune pousse | Extrait sec hydroalcoolique | 75 µg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Regulatory points
- Conditions légales
Betula pendula Roth: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Tilia platyphyllos Scop.
Read the warning, when it applies and the studies cited
Linden - TILIA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; De Smet 1993).
Sources cited by Health Canada (2)
- De Smet PAGM, Keller K, Hansel R, Chandler RF, editors. Adverse Effects of Herbal Drugs, Volume 2. Berlin (DE): Springer-Verlag; 1993.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- Betula pendula Roth
Read the warning, when it applies and the studies cited
Birch
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney or cardiovascular disorders (Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 1998).
Sources cited by Health Canada (4)
- Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R, editors. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council; 1998.
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Bioerum
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Herbetom Controle urique rein detox (Bioerum): composition and regulation”, https://compoatlas.com/en/supplements/products/146021-herbetom-controle-urique-rein-detox, updated 15 November 2026.